Axon Enterprise (NASDAQ:AXON) Downgraded to Neutral Rating by Northcoast Research

Axon Enterprise (NASDAQ:AXONGet Free Report) was downgraded by Northcoast Research from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday,Briefing.com Automated Import reports.

A number of other research analysts have also recently commented on AXON. The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities boosted their target price on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Needham & Company LLC boosted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $542.15.

Read Our Latest Analysis on AXON

Axon Enterprise Trading Up 3.9 %

AXON opened at $710.01 on Wednesday. Axon Enterprise has a one year low of $260.27 and a one year high of $715.99. The stock has a market capitalization of $54.14 billion, a PE ratio of 183.47, a P/E/G ratio of 6.85 and a beta of 1.05. The business’s 50 day moving average price is $625.48 and its 200 day moving average price is $514.81. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the transaction, the president now directly owns 181,892 shares in the company, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,711 shares of company stock valued at $5,631,561. 5.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Axon Enterprise

Large investors have recently bought and sold shares of the business. Fourth Dimension Wealth LLC purchased a new position in Axon Enterprise in the fourth quarter valued at $30,000. Prestige Wealth Management Group LLC boosted its stake in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise in the third quarter valued at $41,000. Finally, Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the fourth quarter valued at $45,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.